Table 1.

Reported studies of expression of Ln-γ2 in cancer of gastrointestinal tract.

Organ	Detection Rate by IHC	Detection Rate by Serological Assay	References
esophagus	44% (44/100)	N/A	[18]
stomach	23% (35/153)	N/A	[20]
colon	65% (29/39)	N/A	[21]
liver	63% (25/40)	CLIA, 63% (36/57)	[22,23]
pancreas	53% (8/15)	ELISA, 72% (36/50)	[16,24]
biliary tract	57% (35/61)	N/A	[25]

N/A; not available.